Minneapolis, MN– Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced that Eck Redmond has joined as its Senior Director of Sales and New Business Development. Eck will lead the organization’s efforts to build a presence in Boston and to support cell and gene therapy developers in the greater Boston area.
“Eck’s 13+ years of experience in the life sciences industry have already proven to be invaluable in our efforts to supply end-to-end solutions for companies driving innovation in cell and gene therapies,” said Chris McClain, Senior Vice President, Sales and Business Development, Be The Match BioTherapies. “We are confident that her knowledge and expertise will continue to advance our customers pursuit of our shared mission to save lives through cellular therapy.”
“I am excited to continue working with Boston area developers that are pursuing life-saving cellular therapies,” noted Eck. “Be The Match BioTherapies is one of the only organizations globally that can offer more than 30 years of experience and infrastructure to support the entire cell therapy supply chain for autologous and allogeneic therapies from discovery through commercialization.”
Before joining Be The Match BioTherapies, Eck worked with precision medicine and gene-editing companies as well as multinational biopharmaceutical and biotechnology companies to provide genomics services and solutions. For the last five years, she consulted with scientists to help accelerate research on pre-clinical and clinical DNA/RNA sequencing and gene synthesis projects.
She has worked directly with GENEWIZ, a Brooks Life Sciences Company (now Azenta Life Sciences), Waters Corporation, and Phenomenex, a Danaher Company. She earned her bachelor’s degree in Biochemistry from McGill University in Montreal, Canada.
